303 related articles for article (PubMed ID: 25940215)
1. Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices.
Lee W; Tay A; Subbiah RN; Walker BD; Kuchar DL; Muthiah K; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Spratt P; Jansz PC; Granger E; Dhital K; Hayward CS
Pacing Clin Electrophysiol; 2015 Aug; 38(8):925-33. PubMed ID: 25940215
[TBL] [Abstract][Full Text] [Related]
2. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
[TBL] [Abstract][Full Text] [Related]
3. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
[TBL] [Abstract][Full Text] [Related]
5. Survival Benefit of Implantable-Cardioverter Defibrillator Therapy in Ambulatory Patients With Left Ventricular Assist Device.
Simsek E; Nalbantgil S; Demir E; Kemal HS; Mutlu I; Ozturk P; Engin C; Yagdi T; Ozbaran M
Transplant Proc; 2019 Dec; 51(10):3403-3408. PubMed ID: 31732208
[TBL] [Abstract][Full Text] [Related]
6. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?
Garan AR; Yuzefpolskaya M; Colombo PC; Morrow JP; Te-Frey R; Dano D; Takayama H; Naka Y; Garan H; Jorde UP; Uriel N
J Am Coll Cardiol; 2013 Jun; 61(25):2542-50. PubMed ID: 23643502
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients.
Refaat MM; Tanaka T; Kormos RL; McNamara D; Teuteberg J; Winowich S; London B; Simon MA
J Card Fail; 2012 Feb; 18(2):140-5. PubMed ID: 22300782
[TBL] [Abstract][Full Text] [Related]
8. Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis.
Vakil K; Kazmirczak F; Sathnur N; Adabag S; Cantillon DJ; Kiehl EL; Koene R; Cogswell R; Anand I; Roukoz H
JACC Heart Fail; 2016 Oct; 4(10):772-779. PubMed ID: 27395347
[TBL] [Abstract][Full Text] [Related]
9. Implantable Cardioverter Defibrillators and Survival in Continuous-Flow Left Ventricular Assist Device Patients.
Kutyifa V; Fernandez G; Sherazi S; Aktas M; Huang D; McNitt S; Papernov A; Wang M; Massey HT; Chen L; Alexis JD
ASAIO J; 2019 Jan; 65(1):49-53. PubMed ID: 29215366
[TBL] [Abstract][Full Text] [Related]
10. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation.
Thomas IC; Cork DP; Levy A; Nayak H; Beshai JF; Burke MC; Moss JD
Pacing Clin Electrophysiol; 2014 Apr; 37(4):464-72. PubMed ID: 24237034
[TBL] [Abstract][Full Text] [Related]
11. The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis.
Clerkin KJ; Topkara VK; Mancini DM; Yuzefpolskaya M; Demmer RT; Dizon JM; Takeda K; Takayama H; Naka Y; Colombo PC; Garan AR
J Heart Lung Transplant; 2017 Jun; 36(6):633-639. PubMed ID: 28089072
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
Raasch H; Jensen BC; Chang PP; Mounsey JP; Gehi AK; Chung EH; Sheridan BC; Bowen A; Katz JN
Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
[TBL] [Abstract][Full Text] [Related]
13. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis.
Agrawal S; Garg L; Nanda S; Sharma A; Bhatia N; Manda Y; Singh A; Fegley M; Shirani J
Int J Cardiol; 2016 Nov; 222():379-384. PubMed ID: 27505320
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
[TBL] [Abstract][Full Text] [Related]
15. Impact of QRS Duration and Ventricular Pacing on Clinical and Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Study.
Gopinathannair R; Roukoz H; Trivedi JR; Cowger J; Bhan A; Ravichandran A; Bhat G; Birks EJ; Slaughter MS; Ahmed MM
J Card Fail; 2019 May; 25(5):355-363. PubMed ID: 30797964
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter-defibrillators and survival in advanced heart failure patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis.
Elkaryoni A; Badarin FA; Khan MS; Ellakany K; Potturi N; Poonia J; Kennedy KF; Magalski A; Sperry BW; Wimmer AP
Europace; 2019 Sep; 21(9):1353-1359. PubMed ID: 31086951
[TBL] [Abstract][Full Text] [Related]
17. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
18. Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices.
Galand V; Flécher E; Auffret V; Boulé S; Vincentelli A; Dambrin C; Mondoly P; Sacher F; Nubret K; Kindo M; Cardi T; Gaudard P; Rouvière P; Michel M; Gourraud JB; Defaye P; Chavanon O; Verdonk C; Ghodbane W; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Litzler PY; Anselme F; Babatasi G; Belin A; Garnier F; Bielefeld M; Hamon D; Radu C; Pierre B; Bourguignon T; Eschalier R; D'Ostrevy N; Bories MC; Marijon E; Vanhuyse F; Blangy H; Verhoye JP; Leclercq C; Martins RP;
JACC Clin Electrophysiol; 2018 Sep; 4(9):1166-1175. PubMed ID: 30236390
[TBL] [Abstract][Full Text] [Related]
19. Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry.
Clerkin KJ; Topkara VK; Demmer RT; Dizon JM; Yuzefpolskaya M; Fried JA; Mai X; Mancini DM; Takeda K; Takayama H; Naka Y; Colombo PC; Garan AR
JACC Heart Fail; 2017 Dec; 5(12):916-926. PubMed ID: 29191299
[TBL] [Abstract][Full Text] [Related]
20. Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device.
Labedi MR; Alharethi R; Kfoury AG; Budge D; Bruce R; Rasmusson B; Bunch TJ
ASAIO J; 2013; 59(2):136-9. PubMed ID: 23438775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
